MeCP2 is a critical focal point for various molecular processes, and impairments mainly caused by pathogenic variants in the MECP2 gene give rise to RTT [20], a systemic disorder impacting several different organ systems, that leads to a wide range of autonomic, cardiac, gastrointestinal, neurological, respiratory, sleep, and skeletal problems. This evidence concerns the gene MECP2 and Rett syndrome.